OneTwo Analytics is deeply rooted in scientific research. Together with our co-founders, the endocrinologists from Uppsala University, Per-Ola Carlsson (MD PhD) and Daniel Espes (Assoc. MD PhD), we are conducting several studies within glucose monitoring.
Our goal is to continuously deepen our understanding of the data flowing daily from glucose sensors, to constantly improve our services.
OneTwo Analytics possesses great knowledge in diabetes. Among the co-founders are the Professor of Medicine and Senior Consultant in diabetes, Per-Ola Carlsson (MD PhD) and the Associate Professor of Medicine and Senior Consultant, Daniel Espes (MD PhD), from Uppsala University. Per-Ola Carlsson is the Chief Medical Officer (CMO) and Daniel Espes is the Chief Scientific Officer (CSO) of OneTwo Analytics.
Sophiahemmet - Periodic Continuous Glucose Monitoring
A randomized controlled trial in collaboration with Sophiahemmet University College and four primary care centers in Sweden. The study aims to investigate the effect of glucose monitoring with CGM combined with a data analysis report to support a person-centered approach compared to traditional treatment involving Self-Monitoring of Blood Glucose (SMBG) through fingerstick testing within type 2 diabetes care.
